Just on that point of ‘Approvals’ given you raised it …. Can you provide a list of the FDA approvals or EUA’s issued for all these cheaper alternative treatments for COVID-19 you have been telling us about for the last 18 months ?
………….
………….
………….
…………. didn’t think so ?
It does make me wonder why you criticise MSB for having no approval or EUA yet for its COVID-19 ARDS treatment but don’t feel the need to substantiate your cheaper alternatives by the same measuring stick - Approvals …. you would have to think it is going to be somewhat difficult for your suggested cheaper alternatives to actually treat people for COVID-19 without an FDA approval or an EAU issued …. and price of treatment aside; it seems like your touted cheaper alternatives are no further advanced than MSB is at present with Remestemcel-L - just sayin’
Watch this space I guess ?
$90 a share on COVID ARDS Authorization ?, page-38
-
- There are more pages in this discussion • 223 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3418 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 24361 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |